Xuan Xu

Dr. Xuan Xu

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HXHaihua Xie
Haihua Xie
JJJia Jiang
Jia Jiang
SCSihui Cao
Sihui Cao
XXXuan Xu
Xuan Xu
JZJingying ZHOU
Jingying ZHOU
MLMi Liu
Mi Liu
Mild cognitive impairment (MCI) represents a transitional stage between normal aging and dementia, often considered critical for dementia prevention. Despite its significance, no effective clinical treatment for MCI has yet been established. Emerging evidence has demonstrated a strong association between trimethylamine-N-oxide (TMAO), a prominent metabolite derived from the gut microbiota, and MCI, highlighting its potential as a biomarker and therapeutic target. TMAO has been implicated in increasing MCI risk through its influence on factors such as hypertension, cardiovascular disease, depression, diabetes, and stroke. Moreover, it contributes to MCI by promoting oxidative stress, disrupting the blood–brain barrier, impairing synaptic plasticity, inducing inflammation, causing mitochondrial metabolic disturbances, and facilitating abnormal protein aggregation. This review further explores therapeutic strategies targeting TMAO to mitigate MCI progression.

24 January 2024
Verified
Book Chapter
Open access
PDF file
MLMi Liu
Mi Liu
LWLiu Weiai
Liu Weiai
SCShe Chang
She Chang
ZJZhou Jingying
Zhou Jingying
XXXuan Xu
Xuan Xu
HHHe Haolong
He Haolong
Gastritis, an inflammation of the stomach lining, arises from diverse causes and ranks among the most frequent digestive ailments. It typically falls into two categories based on the speed of onset: acute and chronic gastritis. Patients with acute gastritis are generally managed symptomatically. Meanwhile, those with chronic gastritis experience ongoing discomfort like epigastric pain, belching, and acid reflux, negatively impacting their quality of life. They can benefit from presently approved medical treatments. To alleviate the physical and mental burden of chronic gastritis and enhance life quality, many patients explore complementary and alternative therapies (CAM). A wide array of CAM options exists, but their safety and effectiveness remain uncertain. If supported by robust evidence, these therapies could potentially become part of standard medical practice for treating chronic gastritis. Approaches like Traditional Chinese Medicine, Acupuncture, Tuina, Diet, Exercise, and Psychological Interventions have demonstrated the capacity to ameliorate symptoms and enhance the well-being of chronic gastritis patients. Identifying high-quality evidence regarding efficacy and safety through Randomized Controlled Trials (RCTs) can facilitate the broader integration of CAM in chronic gastritis treatment. This section offers an overview of the most recent clinical trial findings concerning complementary and alternative therapies.